Contact
searchSearch
HMP Global

News and FDA-Alerts

atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist

Popular Articles

Cosmetic Derm + Skin + Mouth + Botox + Plastic Surgery + Lips + Fillers
News
Hyaluronic Acid Filler Injections for Nonsurgical Facial Aesthetics
03/19/2024
Riya Gandhi, MA
A systematic review of high-level evidence studies provides valuable insights into the spectrum of adverse events associated with hyaluronic acid (HA) filler injections for nonsurgical facial aesthetics.
A systematic review of high-level evidence studies provides valuable insights into the spectrum of adverse events associated with hyaluronic acid (HA) filler injections for nonsurgical facial aesthetics.
A systematic review of...
03/19/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Jessica Garlewicz
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
The ElderDerm: Episode 3, Shared- Decision Making
Podcasts
The ElderDerm: Episode 3, Shared-Decision Making
05/16/2024
Adam Friedman, MD; Jaya Manjunath
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the...
05/16/2024
The Dermatologist
eczema
News
Novel Efficacy Index Compares Long-Term Therapy Outcomes in Atopic Dermatitis Treatments
06/22/2024
Riya Gandhi, MA
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess...
06/22/2024
The Dermatologist
acne
News
Evidence-Based Recommendations for Acne Management
08/09/2024
Jessica Garlewicz
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a...
08/09/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist
Quiz
Psychological and Functional Impact of Eyebrow and Eyelash Loss in AA
02/05/2026
Riya Gandhi, MA
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and...
02/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use